This review summarizes the significant impact of cytomegalovirus (CMV) infection on solid organ and hematopoietic stem cell transplant recipients. A discussion of the various CMV prevention and treatment strategies is provided, including a detailed description of each of the available CMV antiviral drugs.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/jcph.1363 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!